Skip to main content
OpenTrials

Clinical trial condition

Relapsed Refractory Multiple Myeloma (RRMM)

Explore clinical trials studying Relapsed Refractory Multiple Myeloma (RRMM). Study availability and eligibility vary by location and protocol.

8 public trials 7 recruiting studies

Relapsed Refractory Multiple Myeloma (RRMM) trial results

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • Illawarra Cancer care centre, Wollongong Hospital Wollongong, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

NCT06832865

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
  • University of Florida Division of Sponsored Programs Gainesville, Florida, United States
  • University of Kentucky, Markey Cancer Center Clinical Research Organization Lexington, Kentucky, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 159 locations
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • National University Hospital (NUH) Singapore
  • Singhealth Duke NUS blood cancer center Singapore
  • Chonnam National University Hwasun Hospital Hwasun, South Korea
  • Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea